Skip to content
Catalyst

PapersPMID:12499992

Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.

Journal of pediatric gastroenterology and nutrition2003The record ↗

  1. Finding, very limited evidencelowersPlasma phenylalanine concentration

What moved

1 findingHow to read these marks →
  • “Dietary THR supplementation of approximately 50 mg/kg per day resulted in a significant decrease of plasma PHE levels ( P = 0.0234).”
    Study
    crossover
    Duration
    8 weeks
    Dose studied
    oral L-threonine (THR), approximately 50 mg/kg per day for 8 weeks, against a similar amount of maltodextrin as placebo
    Population
    Patients with hyperphenylalaninemia, placebo-controlled crossover (8 weeks supplement, 8 weeks wash-out, 8 weeks crossed over), on special PHE-free amino acid mixture diets

Study record

Design
crossover trial
Species
human
Population
Patients with hyperphenylalaninemia on special PHE-free amino acid mixture diets
Participants
12
Comparator
placebo
Duration
56 days
Endpoints measured
2
Declined
this platform holds no node for the endpoint